BRAF and metastatic malignant neoplasm in the lymph nodes: Adler et al.26 reported that in BRAF-mutant patients, lymph node metastases are more likely to develop as first metastases than as in-transit metastases but do not report the rate of BRAF mutation in their group with ITMs.